EIZURES are a well-known presenting manifestation of brain tumors, particularly LGGs. 8, 12, 18, 20 The association between gliomas and the prevalence of seizures to some degree correlates inversely with tumor grade. Indolent slow-growing tumors, such as LGGs, gangliogliomas, and meningiomas, appear to have a striking predilection for epileptogenesis. As a result, seizures are a significantly favorable prognostic factor for survival. 15, 17, 24 With the increased use of contemporary neuroimaging modalities, the accuracy and timeliness of diagnosing LGGs has been vastly improved, reducing the time between onset of seizures and surgical intervention. Nevertheless, seizures remain the most common presenting symptom of LGGs. Because the median duration of survival of patients with
Clinical Material and Methods

Study Population and Data Collection
Between January 1997 and December 2003, 332 adult patients (Ͼ 18 years of age) underwent surgery at the University of California, San Francisco for treatment of a hemispheric LGG at the time of initial diagnosis. Patients were excluded from the study if they had undergone any previous tumor resection, with the exception of previous biopsies performed as part of a diagnostic workup that led to eventual surgical resection. Data pertaining to patient demographics, seizure-related history, surgical details, neuroimaging, therapeutic management, and outcome were obtained from hospital and departmental records. All research protocols were approved by the University of California, San Francisco institutional review board for human research.
Preoperative data included date of seizure onset, type of seizure (simple partial, complex partial, and/or generalized), other presenting signs and symptoms, and information concerning patients' use of AEDs and steroid medications. The study population was divided into 3 groups classified by preoperative seizure status. The first group had no history of seizures before surgery. The second group of patients had preoperative seizures controlled with medication. Seizure control was defined as the complete absence of seizures during the 3 months before surgery with the use of AEDs. The third group of patients had pharmacoresistant epilepsy before surgery. Patients were considered to have pharmacoresistant epilepsy if they had seizures more than once every 3 months while being treated with AEDs. Clinical characteristics at the time of surgery are presented in Table 1 .
Operative data were recorded, including the use of cortical and subcortical motor stimulation mapping, language mapping, electrocorticography, and neuronavigation. 2 The goal of surgery was gross-total resection of the tumor when possible. Subtotal resection was performed mainly because of tumor involvement in functionally eloquent brain areas as verified by intraoperative stimulation mapping. Extended lesionectomy-that is, resection intended to extend well beyond the tumor margin-was rarely performed. In our center, there has been no defined standard use of electrocorticography in this particular patient population (patients with LGGs presenting with epilepsy). Thus, the use of electrocorticography has largely depended upon the preference of the surgeon, and in those patients (especially Ͻ 18 years of age) who had a very long duration of medically refractory epilepsy, electrocorticography was used with a greater frequency, especially when the tumor was stable and the seizures were the more significant problem. On the other hand, electrocorticography is always used to monitor after discharge potentials are elicited during awake stimulation mapping, as a routine component of that surgical procedure.
Histopathological diagnosis of LGG was limited to surgical specimens that met current WHO criteria for Grade II oligoastrocytoma, oligodendroglioma, or astrocytoma. 13 The MR imaging characteristics of tumors were recorded, including size (largest diameter) and presence or absence of enhancement, cystic components, edema, and mass effect. Extent of resection was designated as gross-total or subtotal according to institutional tumor board review of pre-and postoperative MR images.
The primary outcome measure was seizure status evaluated at 6 and 12 months after surgery using the Engel Classification of Seizures (Class I, seizure free; Class II, rare seizures; Class III, meaningful seizure improvement; and Class IV, no seizure improvement or worsening). 6 This scoring system was applied to the first 6 months following surgery for the 6-month time point and to the second 6 months after surgery for the 12-month time point. Secondary outcome measures included seizure recurrence and KPS score.
Statistical Analysis
Analyses were tailored to address associations between demographic and surgery-related variables and: 1) the presence of preoperative seizures; 2) preoperative seizure control; and 3) postoperative seizure control at 6-and 12-months follow-up. Univariate analyses were carried out using the chi-square test for dichotomous variables and the Mann-Whitney U-test for continuous variables. For outcome analyses, Engel classification was dichotomized as Class I versus Class II-IV; in other words, patients were either completely seizure free or not. Multivariate analyses were performed by entering variables with a probability value Ͻ 0.05 from univariate analyses into a backward stepwise logistic regression. Because of the number of comparisons being made, for all analyses, the level of significance was set at 0.02 rather than the usual 0.05. Statistical analysis was performed using Statview (SAS System) and SAS.
To evaluate whether seizure recurrence predicted tumor progression, a time-dependent Cox proportional hazards model and the Landmark method were applied. Both methods are designed to avoid potential bias due to differences in follow-up time-with the likelihood of observing a progression increasing the longer the patient is followed upand to take into account the temporal relationship between the time tumor progression was identified and the time seizures occurred. The Cox analysis considers the status (seizure free: yes or no) at each time postsurgery that a progression is observed and determines the relative likelihood that the person having the progression had previously begun to have seizures. This information is combined to provide an overall estimate of the relative hazard of progression given the status with regard to seizures. For the Landmark analysis, a fixed time point (18 months postsurgery) was selected, and all patients in whom progression had not occurred by that time were included and the seizure status at that time was determined. Tumor progression (growth or new enhancement) as detected on MR imaging in patients who were seizure free (Engel Class I) at that time was compared with progression in those who had already experienced seizure recurrence using the log-rank test, and a hazard ratio was estimated using the Cox proportional hazards model. Because in this case only 1 hypothesis was being tested, a probability value of 0.05 was considered statistically significant.
Results
Population Characteristics
Of the 332 patients with LGGs, 63 patients (19.0%) had E. F. Chang et al. no preoperative seizures, 137 patients (41.3%) had history of seizures that were controlled, and 132 patients (39.8%) had seizures that were not controlled. With these comparison groups, factors that predisposed patients to the preoperative presence and control of seizures were analyzed. The baseline characteristics of each group are described in Table 1 .
The most common seizure type was generalized (53.5% of patients with seizures), followed by nearly equal numbers of simple partial and complex partial seizures (30.1% and 31.2%, respectively); 24.2% of patients with seizures had partial seizures with secondary generalization. With regard to seizure frequency, 61 patients presented with only 1 episode of a preoperative seizure (44.5% of patients with controlled seizures). During the month before surgery, 65 patients had Ն 1 seizure per week, including 24 patients who had Ն 1 seizure per day (49.2 and 18.2%, respectively, of patients who had uncontrolled seizures). Overall, the median duration between onset of seizures and surgery was 6 months and ranged from 0.2 months to 45 years. Patients with controlled seizures had a median seizure duration of 3 months, and those with uncontrolled seizures had a median duration of 12 months.
All patients who presented with seizures were taking AEDs at the time of surgery. The most commonly used AED was phenytoin. However, among those patients with
J. Neurosurg. / Volume 108 / February 2008
Seizure control after surgery for low-grade gliomas seizures that were uncontrolled preoperatively, phenytoin was used relatively less and other combinations of AEDs were encountered more frequently. This is consistent with our general practice that patients with seizures tend to be prescribed phenytoin as the first-line AED. Other common AEDs included carbamazepine and divalproex sodium ( Table 2) . Fifteen patients were prescribed AEDs without a history of seizures.
229
Factors Predisposing to Seizures in Patients With LGGs
To identify variables that might predispose patients with LGG to present with seizures, baseline characteristics including patient demographic and tumor information were compared between those patients who had preoperative seizures and those who did not. (See Table 1 for a complete list). In univariate analysis, frontal lobe location (p = 0.0012) and histological subtype (p = 0.0001) were associated with the presence of seizures, whereas subcortical location was associated with the absence of seizures (p = 0.001). These variables were entered into a multivariate analysis, which revealed that patients with the histological subtypes of oligoastrocytoma (p = 0.0007) and oligodendroglioma (p = 0.001) were more likely to present with seizures than were patients with astrocytomas, and that patients with LGGs involving midline structures were less likely to present with seizures than were those with cortically located tumors, regardless of the involved lobe (p = 0.0175; Table 3 ).
Factors Influencing Preoperative Seizure Control
The factors influencing preoperative seizure control are not necessarily the same factors that predispose to seizures as a presenting symptom. Therefore, characteristics pertaining to seizure history and baseline characteristics were compared between patients with controlled and those with uncontrolled preoperative seizures (patients who did not present with seizures were not included in this comparison).
Baseline characteristics in addition to seizure features and history were entered in a univariate analysis (Table 1) . Low-grade gliomas involving the temporal lobe (p = 0.017), a longer period of time since seizure onset (p = 0.0001), and seizure type (p = 0.001) were associated with seizures that could not be controlled with AEDs. These variables were entered into multivariate analysis, which revealed that the presence of simple partial seizures (p = 0.0005), a longer duration from seizure onset (p = 0.006), and temporal lobe involvement (p = 0.0089) were associated with uncontrolled preoperative seizures. The presence of generalized seizures appeared to be associated with better seizure control (p = 0.0005; Table 4 ).
Postoperative Seizure Control
Seizure control was evaluated at 6 and 12 months after surgery. Engel classification was determined for each of the 269 patients who presented with a history of seizures (both controlled and uncontrolled; Table 5 , Fig. 1 ) for whom data were available. The postoperative seizure status was proportionally similar at the 2 time points, although status improved in some patients and worsened in others.
Overall, 67% of patients who presented with a history of seizures were completely seizure free at each time point (Class I), 17% had rare seizures (Class II), 7% had meaningful improvement (Class III), and 8% had no improvement (Class IV). In Table 5 , seizure outcomes are shown stratified by patients' preoperative seizure status. Importantly, 50% of patients who had uncontrolled seizures before surgery were seizure free at 6-month follow-up compared with 80% of patients in whom seizures had been controlled preoperatively. Patients who had no seizures before surgery had the highest percentage of seizure control after surgery (94%; p Ͻ 0.005 for comparison between the 3 groups, chi-square test; Fig. 2) . Among those presenting with seizures, patients with preoperatively uncontrolled seizures were more likely to have Class II-IV outcomes at both 6 and 12 months' follow-up (p Ͻ 0.02, chi-square test).
Among those with a preoperative history of seizures in univariate analysis (Table 6) , seizure control at 6 months was predicted by gross-total resection (p Ͻ 0.0001). In contrast, postoperative uncontrolled seizures were predicted by simple partial seizure type (p = 0.0006) and preoperative uncontrolled seizures (p Ͻ 0.001). Duration from seizure onset was also associated with poor seizure control using both continuous (p = 0.004, Mann-Whitney) and dichotomous (Ͻ 3 months compared with Ն 3 months, p = 0.01; Ͻ 12 months compared with Ն 12 months, p = 0.003; chi-square test) variables. These variables were entered into multivariate analysis using logistic regression (Table 7 , Figs. 3 and 4) . Grosstotal resection was a strong predictor of seizure control (OR 16, 95% CI 2.2-124, p = 0.0064), whereas duration Ͼ 1 year (OR 0.285, 95% CI 0.145-0.558, p = 0.0003) and simple partial seizures (OR 0.36, 95% CI 0.18-0.72, p = 0.0042) predicted uncontrolled seizures. Other factors related to lesion location, MR imaging characteristics, and histopathological characteristics as well as chemotherapy and radiation therapy were not associated with postoperative seizure control.
These factors were then applied to the data set to estimate their prognostic value for postoperative seizure control at 6 months. Of 46 patients in whom all 3 favorable prognostic factors (gross-total resection, nonsimple partial seizure history, and duration Ͻ 1 year) were present, 45 (98%) were seizure free at 6 months. Conversely, seizure control was achieved in only 31 (44%) of 70 patients who had none of the favorable prognostic variables (that is, who had subtotal resection or biopsy alone, preoperative simple partial seizures, and duration Ͼ 1 year).
Patients who experienced no improvement in seizure frequency after surgery (Engel Class IV) required various treatments for seizure control. In all cases, a regimen of the maximum tolerated doses of AEDs was continued. The 18 patients who had residual tumor in eloquent brain regions were treated with radiation therapy. Significant reduction in seizure frequency was observed in 10 (56%) of the patients though typically over a longer period after radiation therapy (2-3 years).
Electrocorticography for seizure detection was used at the discretion of the operating surgeon in 63 cases. The use of electrocorticography was not associated with any particular type of seizure history. 8, 22 Seizure foci were identified in 26 of these cases. These foci were resected if they were not located in functionally eloquent areas confirmed by stimulation mapping. Approximately 58% of patients with seizure foci identified during intraoperative electrocorticography (15 of 26 patients) had complete seizure control at 6 months. Incomplete seizure control was found in 19 (51%) of 37 patients in whom no seizure foci could be identified by means of electrocorticography.
Recurrent Seizures as a Predictor of Tumor Progression
Given the strong association between preoperative seizures and primary LGGs, we sought to determine the prognostic significance of postoperative seizures for LGG recurrence for those patients who initially experienced good seizure control after surgery (Engel Class I at 6 months). The time-dependent Cox proportional hazards model was used to determine whether seizure recurrence predicted tumor progression. Postoperative seizure recurrence was found to be associated with tumor progression (p = 0.003). At 6-month follow-up, 161 patients were seizure free and had not experienced tumor progression; 79 of these patients had a known time of tumor progression, and 41 of these 79 had had a seizure prior to progression. Using the timedependent proportional hazards model, the estimated hazard ratio for tumor progression if seizures had recurred compared with their not having recurred was 3.80 (95% CI 1.74-8.29).
The data were also analyzed with the landmark method. We used this method of analysis to evaluate tumor progression for all patients from 18 months after surgery on. Eighteen months was selected as the landmark time because 73 of 161 patients had experienced seizure recurrence by that time, and only 11 patients had had tumor progression (median follow-up = 30 months). Repeating the proportional hazards model starting at 18 months (so that a time-dependent model was not required) provided similar results (hazard ratio 3.57, 95% CI 1.02-12.5, p = 0.03), thereby confirming the association of seizure recurrence and tumor progression.
Seizure Control and KPS Scores
Because seizures play an important role in quality of life and neurological disability, the relationship between the seizure control status and KPS scores was assessed. At both 6 and 12 months after surgery, KPS scores were found to be inversely related to seizure control (Engel class and KPS score analyzed as ordered variables: at 6 months, p Ͻ 0.001; at 12 months, p = 0.001 [Spearman rank correlation]). The median KPS score was 90 for patients with seizure control, which means that patients were typically
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Seizure control after surgery for low-grade gliomas 231 able to carry out activities of normal living with mild symptoms from their disease. Patients without seizure control had a median KPS score of 80, meaning normal activity with effort with more symptoms. As expected, patients with better seizure control had less functional impairment.
Discussion
In this retrospective study, we have documented the clinical factors associated with epileptogenesis and postoperative seizure control in patients with LGGs. We present a large series of patients who were treated at a single institution in the contemporary MR imaging era using current histopathological criteria.
We found that 81% of our patients with LGG present with seizures. The association between cortical location and seizures confirms what has been known for Ͼ 50 years. 9, 30 Historically, seizure patterns were invaluable in the localization of intracranial masses. Oligodendrogliomas tend to be more cortically located, and therefore, patients with these lesions are more prone to seizures than patients with astrocytomas, which tend to be situated in white matter (with or without cortical involvement).
Of the patients who presented with seizures in our study population, ~ 50% had uncontrolled seizures at the time of operation despite AED treatment. Partial seizure type, temporal location, and longer seizure history predisposed to poorer preoperative seizure control. These results are consistent with the known vulnerability of temporal lobe structures to epileptogenesis. Some authors have hypothesized that tumoral mass effect on surrounding parenchyma causes increased pressure and ischemia, disruption of gray matter by glioma, and alteration in inhibitory neurotransmitters in adjacent cortex. 10, 31 The medial temporal lobe structures (amygdala and hippocampus) are among the most epileptogenic areas of the brain (along with the motor cortex), so irritation of these areas is associated with a high rate of seizure production.
The factors associated with freedom from seizures were gross-total resection, preoperative seizure history of Ͻ 1 year, and nonsimple partial seizure type. Ninety-eight per- cent of patients with preoperative seizures were seizure free at 6 months when all 3 favorable predictors for postoperative seizure control were present (that is, gross-total resection, preoperative seizure history of Ͻ 1 year, and nonsimple partial seizure type) compared with only 44% when none were present. This may argue for earlier resection of
LGGs associated with seizures even when other clinical factors (small lesion or lack of progression on neuroimages) do not suggest a need for early surgery.
Authors of other studies have reported similar rates of control. Complete seizure control related to various tumors involving the temporal lobe has been described with postoperative seizure control ranging from 65 to 77%. 4, 18, 19, 32 In these studies gross-total resection was found to be the only significant predictor of seizure control. Zaatreh and colleagues have demonstrated Ͼ 95% reduction of seizures from subtotal lobectomy. 32 Duffau et al. 5 showed that 82% of patients were seizure free after "extended lesionectomy" for medically intractable epilepsy caused by insular LGGs. Lombardi et al. 16 demonstrated that hippocampal atrophy abnormalities on MR images in addition to an LGG were predictive of unsatisfactory seizure control after surgery, and they therefore recommended temporal lobectomy plus amygdalohippocampectomy in those cases. These results have improved dramatically from the earliest studies that cited postoperative seizure control rates on the order of 0-21%; 20, 30 presumably the improvement in seizure control results from improved techniques for more precise and extensive surgical resection
The goals of surgical management of LGGs are to remove the neoplasm totally whenever possible and to achieve seizure control. When AED therapy is used in combination with surgery, it appears to result in significant reduction in seizure frequencies. The control rate, however, has been unsatisfactory in some series, because some patients have continued to experience focal epilepsy during the follow-up period. 11 Antiepileptic drugs are sometimes difficult to administer because of the multiple interactions with chemotherapeutic drugs and corticosteroids. Furthermore, the neurological side effects of AEDs may mimic tumor progression and AEDs may even aggravate depression.
Various options exist for those patients who continue to have seizures postoperatively, although the limited numbers in our series preclude definite conclusions on efficacy. In some patients who had persistent seizures after incomplete resection of tumor due to eloquent location, subsequent radiation therapy appeared to reduce seizure frequency. The mechanism of seizure reduction is unclear, but it may be related to the effects of the treatment on tumor progression, and apparent benefit has been observed in some small published series. 3, 23 Otherwise, persistent seizures are managed with multiple AEDs, often at the maximum tolerated doses. Quality of life and the capacity to resume activities of daily living are important outcomes for patients with LGGs because duration of survival is generally longer in these patients than in those with higher grade gliomas. The correlation between postoperative uncontrolled seizures and lower KPS scores is not surprising given that the presence of seizures alone in an otherwise well-functioning patient lowers the KPS score from 100 to 90. Nonetheless, our findings support those of other studies that have demonstrated that cognition and quality of life are significantly worsened when patients have persistent seizures and when patients use certain AEDs alone.
14 Our practice has typically involved continuing AED therapy for 6 months after surgery. Patients are slowly weaned from the medication if they do not have further seizures. In this study, we have also shown the predictive relevance of seizure recurrence for tumor progression.
The inherent limitations of our findings arise from the retrospective study design and possible selection bias. While gross-total resection as determined by neuroimaging was found to be an important factor for seizure control, volumetric-based analyses are the gold standard for extent of resection assessment. The study was not designed to evaluate intraoperative electrocorticography, and therefore, no definitive conclusions can be drawn regarding its application. Authors of some studies advocate its routine use in patients with a prolonged history of intractable seizures, but it may lead to larger resections than needed for seizure control. 7, 28, 29 Prospective and even well-controlled retrospective studies are lacking on this issue, as variables such as tumor location and seizure history probably exert significant influence.
Our study was not designed to evaluate "medically intractable" epilepsy related to gliomas, because the complete preoperative AED administration history was not always readily accessible. We instead characterized perioperative seizures in all LGG patients, who as a group are at high risk for seizures-although in the modern era of neuroimaging, many LGGs are diagnosed and treated surgically before patients even develop seizures. Nonetheless, some authors have suggested that LGGs associated with intractable seizures are a distinct clinicopathological group, 1, 8 as chronic epilepsy confers better prognosis because of the "strikingly" indolent biological activity.
Differences in outcome between lesionectomy alone and extended lesionectomy cannot be inferred from this study. Our practice, however, has involved tumor resection alone as guided by intraoperative MR image-based guidance, functional mapping, and on occasion, electrocorticography. Our data support that gross-total resection alleviates the irritation to surrounding parenchyma from which seizures appear to arise with good seizure control, although the role for extended resection beyond the tumor mass is unclear.
Conclusions
Seizures are an important symptom associated with
LGGs that significantly impact patients' quality of life. Surgical resection is an effective means of reducing seizure burden on patients with LGGs. A long preoperative history of uncontrolled seizures and simple partial seizure type predisposed to poor postoperative control. Gross-total resection appears to be a critical treatment factor favoring seizure control. When patients are initially seizure free after surgery, seizure recurrence is associated with tumor progression.
